Latest News

Data from a previous MPN LANDMARK survey highlight that many patients with polycythemia vera experience symptoms that lead to reduced quality of life.
Ruxolitinib Receives Positive NICE Opinion for Polycythemia Vera

September 18th 2023

Data from a previous MPN LANDMARK survey highlight that many patients with polycythemia vera experience symptoms that lead to reduced quality of life.

Mohammad Bakri Hammami, MD, highlights a need to address socio-racial disparities among Black and non-Black patients with primary myelofibrosis to ensure that everyone receives high-quality treatment.
Socio-Racial Factors May Impact Primary Myelofibrosis Outcomes

September 7th 2023

Marisol Miranda-Galvis, DDS, MS, PhD, highlights the importance of identifying populations of patients with hematologic cancer who are underserved and using socially targeted solutions.
Health Insurance, Income, and Marital Status Contribute to Blood Cancer Disparities

September 7th 2023

Data from a phase 2 trial support a supplemental new drug application for isavuconazonium sulfate as a treatment for pediatric patients with invasive aspergillosis or invasive mucormycosis.
FDA Accepts sNDA for Isavuconazonium Sulfate in Pediatric Fungal Infections

August 11th 2023

Erdheim-Chester Disease: A Case Report of BRAF V600E–Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review
Erdheim-Chester Disease: A Case Report of BRAF V600E–Negative, MAP2K1-Positive ECD Diagnosed by Blood Next-Generation Sequencing Assay and a Brief Literature Review

July 27th 2023

Video Series
Video Interviews
Podcasts
Latest CME Events & Activities

Advances In™: Meeting Unmet Clinical Needs in AML with Evolving Therapeutic Approaches

View More

Bridging the Care Gap in Anemia in CKD: A Comprehensive Guide to Enhancing Patient Care

Register Now!

Antibody-Drug Conjugates in Gynecological Cancer – Setting the Stage

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Burst CME: Regulatory Approval Pathways for Influenza Vaccines

View More

4th Annual Virtual Tumor Board®: Diagnosis and Management of Polycythemia Vera and Myelofibrosis

View More

Medical Crossfire®: Experts Address Your Burning Questions on the Evolving Treatment of MF, PV, and ET!

View More

Oncology Consultations®: Leveraging Clinical Data and Trials to Inform Treatment for Patients with PV

View More

Clinical Interchange™: Improving Outcomes and Overcoming Barriers to Equitable Care in African American Patients With Multiple Myeloma

View More

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

Oncology Town Hall™: Primary Investigators Present Key Abstracts in the Management of CLL

View More

Bridging Clinical Gaps in Indolent and Aggressive B-Cell Lymphomas: The Investigators Demonstrate How Novel Mechanisms Will Impact Your Practice Tomorrow

View More

Updates from the Annual Hematology Meeting: Matching the Tumor with Patient Specific Goals to Inform Frontline Selection and Sequencing in Chronic Lymphocytic Leukemia

View More

Follicular Lymphoma Workshop: Forging Patient-Centric Plans with Targeted Therapies Across Lines of Care

View More

State-of-the-Art CMV Care: Experts’ Perspectives on Primary/Secondary Prevention and Management of Refractory/Resistant Infections

View More

Sickle Cell Disease: Improving the Quality and Continuum of Acute and Ambulatory Patient Care

View More

Transfusion-Related Iron Overload–Evidence-Based Approaches to Improve Chelation Outcomes

View More

Cancer Summaries and Commentaries™: Report from New Orleans on the Latest Updates in the Treatment of MPNs

View More

Medical Crossfire®: How The Experts Treat Acute Lymphoblastic Leukemia: Case Discussions from Adolescent to Adult

View More

Medical Crossfire®: How Do We Apply the Latest Evidence on Novel Therapies to Prevent and Treat GVHD?

View More

"D" is for Diagnosis: Deciphering Uncommon Hematologic Disorders Through the Eyes of a Detective

View More

MRD Assessment as a Cornerstone to Clinical Decision-Making in Hematologic Malignancies: Techniques, Utilization, and Best Practices to Optimize Patient Outcomes

View More

Community Practice Connections™: How We Do It: Application of State-of-the-Art MF and PV Care Today… With An Eye Toward How New Evidence and Combinations Will be Leveraged Tomorrow

View More

Amplifying the Role of Accurate Diagnosis and New Therapeutic Options in the Treatment of Hemolytic Anemias

View More

Community Practice Connections™: Transforming How We Treat Sickle Cell Disease: Holistic Approaches to Addressing Clinical Challenges Across the Patient’s Lifespan

View More

Community Practice Connections™: Visualizing New Treatment Pathways for Anemia in Chronic Kidney Disease

View More

Community Practice Connections™: Exploring the Potential Role for Gene Therapy in Hemophilia B

View More

Oncology Roundtable: Treating MF and PV in 2023

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

More News